Dysport (Galderma Laboratories, L.P.)
Welcome to the PulseAid listing for the Dysport drug offered from Galderma Laboratories, L.P.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Galderma Laboratories, L.P. |
| NON-PROPRIETARY NAME: | Botulinum Toxin Type A |
| SUBSTANCE NAME: | BOTULINUM TOXIN TYPE A |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-11-02 |
| END MARKETING DATE: | 0000-00-00 |
Dysport HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dysport from Galderma Laboratories, L.P. |
| LABELER NAME: | Galderma Laboratories, L.P. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(U/1) |
| START MARKETING DATE: | 2009-11-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0299-5962_2538f3cc-f8a8-44e2-bebe-7cd8842b7a39 |
| PRODUCT NDC: | 0299-5962 |
| APPLICATION NUMBER: | BLA125274 |
Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:
